MA45721A - Procédés de purification de protéines contenant des fragments fc - Google Patents
Procédés de purification de protéines contenant des fragments fcInfo
- Publication number
- MA45721A MA45721A MA045721A MA45721A MA45721A MA 45721 A MA45721 A MA 45721A MA 045721 A MA045721 A MA 045721A MA 45721 A MA45721 A MA 45721A MA 45721 A MA45721 A MA 45721A
- Authority
- MA
- Morocco
- Prior art keywords
- fragments
- processes
- protein containing
- purifying protein
- purifying
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/34—Size-selective separation, e.g. size-exclusion chromatography; Gel filtration; Permeation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3804—Affinity chromatography
- B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
- B01D15/424—Elution mode
- B01D15/426—Specific type of solvent
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/35—Valency
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Water Supply & Treatment (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Storage Device Security (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662365943P | 2016-07-22 | 2016-07-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA45721A true MA45721A (fr) | 2019-05-29 |
Family
ID=59656168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA045721A MA45721A (fr) | 2016-07-22 | 2017-07-21 | Procédés de purification de protéines contenant des fragments fc |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11312745B2 (enExample) |
| EP (1) | EP3487867A2 (enExample) |
| JP (2) | JP7092744B2 (enExample) |
| KR (2) | KR102579850B1 (enExample) |
| CN (2) | CN115925780B (enExample) |
| AU (2) | AU2017298984B2 (enExample) |
| CA (2) | CA3218290A1 (enExample) |
| IL (2) | IL285146B (enExample) |
| MA (1) | MA45721A (enExample) |
| MX (2) | MX2019000903A (enExample) |
| SG (1) | SG11201900573UA (enExample) |
| WO (1) | WO2018018011A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020061478A2 (en) * | 2018-09-21 | 2020-03-26 | Teneobio, Inc. | Methods for purifying heterodimeric, multispecific antibodies |
| MX2021003976A (es) * | 2018-10-11 | 2021-05-27 | Amgen Inc | Procesamiento posterior de constructos de anticuerpos biespecificos. |
| EA202191961A1 (ru) * | 2019-01-16 | 2021-12-13 | Ридженерон Фармасьютикалз, Инк. | Способ и система идентификации и количественного определения фрагментации антител |
| KR102286892B1 (ko) * | 2019-07-08 | 2021-08-06 | 삼천당제약주식회사 | 안과용 단백질 제제의 정제방법 |
| CN110724204B (zh) * | 2019-11-18 | 2021-10-22 | 广东菲鹏制药股份有限公司 | Fc融合蛋白的纯化方法 |
| CN112881675A (zh) * | 2019-11-29 | 2021-06-01 | 广东菲鹏生物有限公司 | IgM抗体检测稀释液 |
| KR20220166814A (ko) | 2020-04-09 | 2022-12-19 | 싸이톰스 테라퓨틱스, 인크. | 활성화 가능한 항체를 함유하는 조성물 |
| US20220081468A1 (en) * | 2020-09-16 | 2022-03-17 | Waters Technologies Corporation | Size exclusion chromatography utilizing low concentration amino acids in size exclusion chromatography mobile phase |
| MX2024004764A (es) * | 2021-10-19 | 2024-07-04 | Alteogen Inc | Procedimiento para purificar una proteína de fusión que tiene un dominio fc de igg. |
| CN113980092B (zh) * | 2021-12-09 | 2024-05-14 | 上海药明生物技术有限公司 | 一种蛋白质亲和纯化方法 |
| CN116165290B (zh) * | 2021-12-17 | 2025-06-27 | 复旦大学 | 一种抗体药物研发流程中工程细胞株的筛选方法 |
| CN116271982B (zh) * | 2022-11-30 | 2024-01-09 | 杭州广科安德生物科技有限公司 | 一种血液高丰度蛋白免疫亲和柱的再生方法 |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4968607A (en) | 1987-11-25 | 1990-11-06 | Immunex Corporation | Interleukin-1 receptors |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| WO1990005183A1 (en) | 1988-10-31 | 1990-05-17 | Immunex Corporation | Interleukin-4 receptors |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US6713610B1 (en) | 1990-01-12 | 2004-03-30 | Raju Kucherlapati | Human antibodies derived from immunized xenomice |
| DE69133566T2 (de) | 1990-01-12 | 2007-12-06 | Amgen Fremont Inc. | Bildung von xenogenen Antikörpern |
| US6673986B1 (en) | 1990-01-12 | 2004-01-06 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| US5350683A (en) | 1990-06-05 | 1994-09-27 | Immunex Corporation | DNA encoding type II interleukin-1 receptors |
| WO1991018982A1 (en) | 1990-06-05 | 1991-12-12 | Immunex Corporation | Type ii interleukin-1 receptors |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US6300129B1 (en) | 1990-08-29 | 2001-10-09 | Genpharm International | Transgenic non-human animals for producing heterologous antibodies |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5874299A (en) | 1990-08-29 | 1999-02-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US6255458B1 (en) | 1990-08-29 | 2001-07-03 | Genpharm International | High affinity human antibodies and human antibodies against digoxin |
| US5877397A (en) | 1990-08-29 | 1999-03-02 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| KR100272077B1 (ko) | 1990-08-29 | 2000-11-15 | 젠팜인터내셔날,인코포레이티드 | 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물 |
| WO1994002602A1 (en) | 1992-07-24 | 1994-02-03 | Cell Genesys, Inc. | Generation of xenogeneic antibodies |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US6130364A (en) | 1995-03-29 | 2000-10-10 | Abgenix, Inc. | Production of antibodies using Cre-mediated site-specific recombination |
| JP4312259B2 (ja) | 1995-04-27 | 2009-08-12 | アムジェン フレモント インク． | 免疫したゼノマウス（ＸｅｎｏＭｏｕｓｅ）に由来するヒト抗体 |
| DE69738539T2 (de) | 1996-12-03 | 2009-03-26 | Amgen Fremont Inc. | Vollkommen humane Antikörper die EGFR binden |
| US6271349B1 (en) | 1996-12-23 | 2001-08-07 | Immunex Corporation | Receptor activator of NF-κB |
| EP1071769A1 (en) * | 1998-04-16 | 2001-01-31 | Genentech, Inc. | Secretion of glycosylated proteins using a tissue plasminogen activator pro-sequence |
| US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
| US20030133939A1 (en) | 2001-01-17 | 2003-07-17 | Genecraft, Inc. | Binding domain-immunoglobulin fusion proteins |
| WO2006047340A2 (en) | 2004-10-22 | 2006-05-04 | Amgen Inc. | Methods for refolding of recombinant antibodies |
| EA201100177A1 (ru) * | 2005-06-17 | 2011-06-30 | Элан Фарма Интернэшнл Лимитед | СПОСОБЫ ОЧИСТКИ АНТИТЕЛ К β-АМИЛОИДУ |
| CA2636109A1 (en) * | 2006-01-06 | 2007-07-19 | Amgen Inc. | Methods and systems for isolating target molecules from complex solutions by column-chromatography using eluants containing organic solvents |
| CN105837690A (zh) | 2006-06-12 | 2016-08-10 | 新兴产品开发西雅图有限公司 | 具有效应功能的单链多价结合蛋白 |
| US10982250B2 (en) * | 2006-09-18 | 2021-04-20 | Genentech, Inc. | Methods of protein production |
| US8198409B2 (en) | 2007-05-21 | 2012-06-12 | Nomadic Bioscience Co., Ltd. | Polypeptide, an affinity chromatography material, and a method for separating and/or purifying immunoglobulin |
| PT2235064E (pt) | 2008-01-07 | 2016-03-01 | Amgen Inc | Método de preparação de moléculas heterodiméricas de fc de anticorpos utilizando efeitos de indução eletrostática |
| JP5529869B2 (ja) | 2008-08-14 | 2014-06-25 | メルク・シャープ・アンド・ドーム・コーポレーション | プロテインａアフィニティークロマトグラフィーを用いる抗体の精製方法 |
| JP5808323B2 (ja) | 2009-06-22 | 2015-11-10 | アムジエン・インコーポレーテツド | 化学的に制御されたレドックス状態を用いたタンパク質のリフォールディング |
| EP3660032B1 (en) * | 2009-06-25 | 2025-10-22 | Amgen Inc. | Capture purification processes for proteins expressed in a non-mammalian system |
| CA2781519A1 (en) | 2009-09-16 | 2011-03-24 | Genentech, Inc. | Coiled coil and/or tether containing protein complexes and uses thereof |
| CN102382190B (zh) * | 2010-09-01 | 2014-04-09 | 山东新时代药业有限公司 | 分离和去除TNFR-Fc融合蛋白中寡聚体的方法 |
| EP2657254A4 (en) | 2010-12-24 | 2014-01-08 | Asahi Kasei Medical Co Ltd | PROCESS FOR IMMOBILIZING THE TEMPERATURE-REACTIVE PROTEIN A |
| CN103814044A (zh) * | 2011-07-08 | 2014-05-21 | 默沙东公司 | 纯化fc-融合蛋白的方法 |
| EP2831096B1 (en) | 2012-03-28 | 2020-04-29 | GE Healthcare BioProcess R&D AB | Affinity chromatography matrix |
| EP2889617B1 (en) | 2012-08-27 | 2017-10-11 | Asahi Kasei Medical Co., Ltd. | Antibody purification method by means of temperature-responsive chromatography |
| UY35148A (es) * | 2012-11-21 | 2014-05-30 | Amgen Inc | Immunoglobulinas heterodiméricas |
| US20140302037A1 (en) | 2013-03-15 | 2014-10-09 | Amgen Inc. | BISPECIFIC-Fc MOLECULES |
| BR112016009919A2 (pt) * | 2013-11-04 | 2017-12-05 | Glenmark Pharmaceuticals Sa | imunoglobulina hetero-dimérica ou fragmento da mesma e método para produzir in vitro uma imunoglobulina hetero-dimérica ou fragmento da mesma |
-
2017
- 2017-07-21 IL IL285146A patent/IL285146B/en unknown
- 2017-07-21 CA CA3218290A patent/CA3218290A1/en active Pending
- 2017-07-21 MA MA045721A patent/MA45721A/fr unknown
- 2017-07-21 KR KR1020227028721A patent/KR102579850B1/ko active Active
- 2017-07-21 US US16/093,994 patent/US11312745B2/en active Active
- 2017-07-21 CN CN202210979746.6A patent/CN115925780B/zh active Active
- 2017-07-21 JP JP2019503247A patent/JP7092744B2/ja active Active
- 2017-07-21 SG SG11201900573UA patent/SG11201900573UA/en unknown
- 2017-07-21 CA CA3031469A patent/CA3031469C/en active Active
- 2017-07-21 MX MX2019000903A patent/MX2019000903A/es unknown
- 2017-07-21 CN CN201780045463.1A patent/CN109563125B/zh active Active
- 2017-07-21 EP EP17754514.2A patent/EP3487867A2/en active Pending
- 2017-07-21 WO PCT/US2017/043384 patent/WO2018018011A2/en not_active Ceased
- 2017-07-21 KR KR1020197003162A patent/KR102435801B1/ko active Active
- 2017-07-21 AU AU2017298984A patent/AU2017298984B2/en active Active
-
2019
- 2019-01-21 MX MX2023006291A patent/MX2023006291A/es unknown
- 2019-01-21 IL IL264375A patent/IL264375B/en unknown
-
2022
- 2022-06-15 JP JP2022096278A patent/JP7411020B2/ja active Active
-
2023
- 2023-08-31 AU AU2023222915A patent/AU2023222915A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20190037247A (ko) | 2019-04-05 |
| JP7092744B2 (ja) | 2022-06-28 |
| KR102579850B1 (ko) | 2023-09-18 |
| CA3031469C (en) | 2025-11-18 |
| JP7411020B2 (ja) | 2024-01-10 |
| AU2017298984A1 (en) | 2019-02-07 |
| US20190127418A1 (en) | 2019-05-02 |
| CN109563125B (zh) | 2022-08-09 |
| EP3487867A2 (en) | 2019-05-29 |
| CA3218290A1 (en) | 2018-01-25 |
| WO2018018011A2 (en) | 2018-01-25 |
| IL285146B (en) | 2022-09-01 |
| MX2019000903A (es) | 2019-05-15 |
| CN109563125A (zh) | 2019-04-02 |
| KR102435801B1 (ko) | 2022-08-25 |
| MX2023006291A (es) | 2023-06-13 |
| IL264375A (en) | 2019-02-28 |
| KR20220120716A (ko) | 2022-08-30 |
| IL264375B (en) | 2021-09-30 |
| AU2017298984B2 (en) | 2023-08-31 |
| WO2018018011A3 (en) | 2018-03-01 |
| CN115925780B (zh) | 2025-11-04 |
| AU2023222915A1 (en) | 2023-09-21 |
| JP2019528255A (ja) | 2019-10-10 |
| CA3031469A1 (en) | 2018-01-25 |
| SG11201900573UA (en) | 2019-02-27 |
| CN115925780A (zh) | 2023-04-07 |
| JP2022120138A (ja) | 2022-08-17 |
| US11312745B2 (en) | 2022-04-26 |
| IL285146A (en) | 2021-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA45721A (fr) | Procédés de purification de protéines contenant des fragments fc | |
| EP3436473A4 (en) | METHOD FOR PURIFYING FC FUSION PROTEINS | |
| EP3731863A4 (en) | ADENO-ASSOCIATED VIRUS CLEANSING PROCEDURES | |
| EP2953965A4 (en) | PROTEIN PURIFICATION PROCESS | |
| EP3004135A4 (en) | PROCESS FOR CLEANING PROTEINS | |
| EP2883882A4 (en) | PROTEIN PURIFICATION PROCESS | |
| EP3398965A4 (en) | METHOD FOR PROMOTING THE EFFICIENCY OF CLEANING POLYPEPTIDE WITH FC REGION | |
| EP3429615A4 (en) | PROCEDURE FOR CLEANING COLLAGEN 7 | |
| EP3240804A4 (en) | ANTI-MYOSTATIN ANTIBODIES, POLYPEPTIDES WITH DEVIANT FC REGIONS AND METHOD OF USE | |
| EP3990031A4 (en) | Adeno-associated virus purification methods | |
| MX392274B (es) | Cartuchos utiles en limpieza de soluciones de dialisis. | |
| MA39774A (fr) | Procédés chimiques pour produire des nucléotides étiquetés | |
| EP2575847A4 (en) | PROCESS FOR PURIFYING POLYPEPTIDES | |
| FR3014901B1 (fr) | Procede de purification de virus ou vecteurs viraux enveloppes | |
| FR3025515B1 (fr) | Procede de purification d'un anticorps monoclonal | |
| EP3325614A4 (en) | PROCESS FOR CLEANING ADENOVIRUS VECTORS | |
| EP2975020A4 (en) | PROCESS FOR CLEANING 1,5-DIAMINOPENTANE | |
| IL261040B (en) | Protein purification | |
| EP3521299A4 (en) | Method for purifying recombinant protein | |
| MA41941A (fr) | Procédé de purification de protéines | |
| PL3307996T3 (pl) | Układ oczyszczania gazów spalinowych | |
| EP3412623A4 (en) | Purification method | |
| EP3318552A4 (en) | PROCESS FOR CLEANING METHIONINE | |
| EP3438426A4 (en) | Exhaust purification system | |
| FR3039433B1 (fr) | Methode d'epuration selective d'aerosols |